{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:21Z","timestamp":1786118841158,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jcrs.2007.07.041","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T15:17:55Z","timestamp":1196867875000},"page":"2122-2128","source":"Crossref","is-referenced-by-count":10,"title":["Safety and efficacy of intracapsular tranilast microspheres in experimental posterior capsule opacification"],"prefix":"10.1097","volume":"33","author":[{"given":"Man","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 1","key":"R2-39-20210210","first-page":"S70","article-title":"Elimination of cataract blindness: a global perspective entering the new millennium.","volume":"45","author":"Apple","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"R3-39-20210210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0886-3350(99)80020-0","article-title":"Posterior capsule opacification. Part 1: experimental investigations.","volume":"25","author":"Nishi","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R5-39-20210210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0161-6420(00)00589-3","article-title":"Eradication of posterior capsule opacification; documentation of a marked decrease in Nd:YAG laser posterior capsulotomy rates noted in an analysis of 5416 pseudophakic human eyes obtained postmortem.","volume":"108","author":"Apple","year":"2001","journal-title":"Ophthalmology"},{"key":"R7-39-20210210","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0161-6420(97)30146-8","article-title":"Evaluation of visual function following neodymium:YAG laser posterior capsulotomy.","volume":"104","author":"Magno","year":"1997","journal-title":"Ophthalmology"},{"key":"R8-39-20210210","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bjo.80.12.1087","article-title":"Mitomycin against posterior capsular opacification: an experimental study in rabbits.","volume":"80","author":"Haus","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"R9-39-20210210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000267875","article-title":"Prevention of secondary cataract by antimitotic drugs: experimental study.","volume":"28","author":"Ismail","year":"1996","journal-title":"Ophthalmic Res"},{"key":"R10-39-20210210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0886-3350(97)80244-1","article-title":"Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report.","volume":"23","author":"Nishi","year":"1997","journal-title":"J Cataract Refract Surg"},{"key":"R11-39-20210210","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0886-3350(00)00326-6","article-title":"Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification.","volume":"26","author":"Meacock","year":"2000","journal-title":"J Cataract Refract Surg"},{"key":"R12-39-20210210","first-page":"2425","article-title":"Cytotoxic effects of FGF2-saporin on bovine epithelial lens cells in vitro.","volume":"36","author":"Behar-Cohen","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-39-20210210","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0886-3350(96)80176-3","article-title":"Inhibition of migrating lens epithelial cells by sustained release of ethylenediaminetetraacetic acid.","volume":"22","author":"Nishi","year":"1996","journal-title":"J Cataract Refract Surg"},{"key":"R14-39-20210210","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0886-3350(98)80352-0","article-title":"Inhibition of posterior capsule opacification with an immunotoxin specific for lens epithelial cells: 24 month clinical results.","volume":"24","author":"Clark","year":"1998","journal-title":"J Cataract Refract Surg"},{"key":"R15-39-20210210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0886-3350(00)00886-5","article-title":"Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents.","volume":"27","author":"Inan","year":"2001","journal-title":"J Cataract Refract Surg"},{"key":"R16-39-20210210","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0886-3350(13)80609-8","article-title":"Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system.","volume":"19","author":"Legler","year":"1993","journal-title":"J Cataract Refract Surg"},{"key":"R17-39-20210210","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0886-3350(96)80120-9","article-title":"Inhibition of posterior capsule opacification by an intraocular-lens-bound sustained drug delivery system: an experimental animal study and literature review.","volume":"22","author":"Tetz","year":"1996","journal-title":"J Cataract Refract Surg"},{"key":"R18-39-20210210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0886-3350(01)01069-0","article-title":"Intracapsular ring sustained 5-fluorouracil delivery system for prevention of posterior capsule opacification in rabbits: a histological study.","volume":"28","author":"Pandey","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R19-39-20210210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0192-0561(00)00013-8","article-title":"Inhibition of interleukin 5 production with no influence on interleukin 4 production by an anti-allergic drug, tranilast, in Toxocara canis-infected mice.","volume":"22","author":"Hiratochi","year":"2000","journal-title":"Int J Immunopharmacol"},{"issue":"4","key":"R23-39-20210210","first-page":"L71","article-title":"Inhibition by tranilast of vascular endothelial growth factor (VEGF)vascular permeability factor (VPF)-induced increase in vascular permeability in rats.","volume":"63","author":"Isaji","year":"1998","journal-title":"Life Science"},{"key":"R24-39-20210210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.1289","article-title":"N-3,4-dimethoxycinnamoyl-anthranilic acid (tranilast) inhibits transforming growth factor- release and reduces migration and invasiveness of human malignant glioma cells.","volume":"93","author":"Platten","year":"2001","journal-title":"Int J Cancer"},{"key":"R25-39-20210210","first-page":"3463","article-title":"Frequent eye irritation study of a short-term and subacute toxicity of tranilast (N-5) ophthalmic solution in rabbits.","volume":"26","author":"Nagata","year":"1992","journal-title":"Japanese Kiso-to-Rinsho"},{"key":"R26-39-20210210","first-page":"429","article-title":"Long-term clinical study of tranilast ophthalmic solution on vernal conjunctivitis.","volume":"9","author":"Kogure","year":"1993","journal-title":"J Clin Ther Med"},{"key":"R28-39-20210210","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0886-3350(99)00211-4","article-title":"Effect of tranilast eyedrops in preventing posterior capsule opacification: preliminary report.","volume":"25","author":"Tobari","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"R29-39-20210210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0021-5155(02)00541-5","article-title":"Effect of various eye drops on corneal wound healing after superficial keratectomy in rabbits.","volume":"46","author":"Tani","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"R30-39-20210210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s004170050298","article-title":"The effect of tranilast on experimental proliferative vitreoretinopathy.","volume":"237","author":"Ito","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R31-39-20210210","first-page":"459","article-title":"Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat.","volume":"40","author":"Takehana","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R32-39-20210210","first-page":"961","article-title":"Drug delivery for posterior segment eye disease.","volume":"41","author":"Geroski","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-39-20210210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery.","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"R37-39-20210210","first-page":"1715","article-title":"Digital image capture and automated analysis of posterior capsular opacification.","volume":"40","author":"Friedman","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R38-39-20210210","first-page":"442","article-title":"Effect of different concentrations of tranilast on posterior capsule opacification.","volume":"105","author":"Miyazawa","year":"2001","journal-title":"Japanese Nippon Ganka Gakkai Zasshi"},{"key":"R39-39-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systemsrecent advances.","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog Retin Eye Res"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335007016070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335007016070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2007.07.041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:55:43Z","timestamp":1786035343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-200712000-00039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2007.07.041","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}